News and Events
12/2017: Four projects successfully completed in Q4
Laronidase, Ipilimumab, Natalizumab, Pembrolizumab.
These 4 cell line development projects were successfully ...read more
11/2017: New CEO
UGA Biopharma announces that Dr. Lars Kober, who was holding Operational Management for many years took over the management of UGA.
...read more
10/2017: Abzena and UGA Biopharma collaborate to treat MS
See our latest press release using that
...read more
09/2017: First CHOice - product promotion in transkript Vol 9
See the current product promotion for our High-Performance Cell Culture Medium First CHOice® published in transkript journal Vol. 9 page 41 via this ...read more
08/2017: Collaboration between Batavia Biosciences and UGA Biopharma
Both companies have the ambition to provide services and technologies supporting the development of high quality and affordable biopharmaceuticals. Through the partnership, two enzyme expressing ...read more
07/2017: Meet us at "New & Emerging Technologies" in Potsdam
You can meet us at the congress "New & Emerging ...read more
05/2017: UGA Biopharma presented at Bionnale 2017
Pitch presentation "Cell lines for biosimilar and NBE manufacturing + services"...read more
04/2017: Opening of additional development labs at UGA Biopharma
UGA Biopharma will open additional laboratories featuring state-of-the-art equipment at the Hennigsdorf site for cell line development and analytical contract services. The extension is tailor-made ...read more
03/2017: Launch of High Speed Workflow
UGA has launched an improved cell-line-development workflow ("High Speed Workflow"), which guarantees cell line development on a shortened time ...read more
Contact
UGA Biopharma GmbHNeuendorfstraße 20a
16761 Hennigsdorf
Germany
E-mail: info@ugabiopharma.com
Phone: +49(0)3302 / 2024900